Press release
Acute On Chronic Liver Failure (ACLF) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Which drivers are expected to have the greatest impact on the over the acute on chronic liver failure (aclf) market's growth?The growing focus on precision and personalized medicine is anticipated to propel the acute-on-chronic liver failure market. Precision and personalized medicine involve tailoring treatments to individuals based on their genetic, environmental, and lifestyle factors to improve outcomes. The rising adoption of personalized medicine is driven by advancements in genomics, biomarker-based diagnostics, enhanced data analytics, and an increasing demand for targeted therapies. These approaches help manage acute-on-chronic liver failure (ACLF) by customizing treatments based on a patient's genetic profile, disease severity, and biomarker data, facilitating more effective therapeutic interventions. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, up from 12 in 2022. Therefore, the expanding focus on precision and personalized medicine is driving the acute-on-chronic liver failure market.
Get Your Acute On Chronic Liver Failure (ACLF) Market Report Here:
https://www.thebusinessresearchcompany.com/report/acute-on-chronic-liver-failure-aclf-global-market-report
What is the future CAGR of the acute on chronic liver failure (aclf) market, and how will it impact industry expansion?
The acute on chronic liver failure (ACLF) market has grown considerably in recent years. It is projected to increase from $2.68 billion in 2024 to $2.89 billion in 2025, at a CAGR of 8.0%. The key contributors to historical growth include the rising prevalence of chronic liver diseases, increasing awareness about liver health, higher healthcare expenditures, the development of novel therapies, a rise in alcohol-related liver damage, a growing number of organ transplant procedures, advancements in critical care, an aging population, and expanding research on liver failure mechanisms.
The acute on chronic liver failure (ACLF) market size is projected to see strong growth in the upcoming years. By 2029, it is anticipated to reach $3.89 billion at a compound annual growth rate (CAGR) of 9.8%. The forecasted expansion is attributed to the increasing adoption of liver support devices, progress in regenerative medicine, a growing focus on precision medicine, rising demand for minimally invasive treatments, the development of targeted therapies, expansion of healthcare infrastructure in emerging markets, increased investment in research and development, a higher prevalence of metabolic disorders, and strengthening public-private partnerships. Notable trends during this period include the integration of artificial intelligence in diagnostics, the advancement of bioengineered liver tissue, improvements in extracorporeal liver support devices, the application of machine learning for personalized treatment plans, the emergence of gene editing technologies, enhancements in liquid biopsy techniques, the development of targeted drug delivery systems, progress in 3D bioprinting for liver regeneration, the adoption of wearable health monitoring devices, and advancements in nanotechnology-based therapies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21081&type=smp
What are the most significant trends transforming the acute on chronic liver failure (aclf) market today?
In the acute-on-chronic liver failure (ACLF) market, companies are conducting clinical trials to develop novel therapeutics and regenerative medicine approaches. A-TANGO, a Spain-based EU horizon-funded project, aims to treat patients with ACLF through a combinatorial therapy that targets inflammation and promotes liver cell regeneration. The G-TAK trial, set for September 2024, will test this novel treatment across multiple liver centers in the UK.
Which key market segments comprise the acute on chronic liver failure (aclf) market and drive its revenue growth?
The acute on chronic liver failure (ACLF) market covered in this report is segmented -
1) By Type Of Treatment: Pharmacological, Supportive Care
2) By Mode Of Administration: Oral, Intravenous (IV)
3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Pharmacological: Antibiotics, Anti-inflammatory Drugs, Vasopressors, Immunomodulators, Antiviral Agents
2) By Supportive Care: Liver Dialysis, Plasma Exchange, Nutritional Support, Mechanical Ventilation, Renal Replacement Therapy (RRT)
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21081
What regions are at the forefront of acute on chronic liver failure (aclf) market expansion?
North America was the largest region in the acute on chronic liver failure (ACLF) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute on chronic liver failure (ACLF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the acute on chronic liver failure (aclf) market?
Major companies operating in the acute on chronic liver failure (ACLF) market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GSK plc, Eli Lilly and Company, Gilead Sciences Inc, Novo Nordisk A/S, Astellas Pharma Inc., CSL Behring, Grifols S.A., Lupin Pharmaceutical Limited, Ferring Pharmaceuticals, Shire plc, Gyre Therapeutics Inc., Dr. Falk Pharma GmbH, Genfit, eGenesis Inc., Conatus Pharmaceuticals Inc., Cellaion SA, Rheacell GmbH & Co. KG, Martin Pharmaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21081&type=smp
What Is Covered In The Acute On Chronic Liver Failure (ACLF) Global Market Report?
•Market Size Forecast: Examine the acute on chronic liver failure (aclf) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the acute on chronic liver failure (aclf) market for a structured understanding.
•Key Players Overview: Analyze major players in the acute on chronic liver failure (aclf) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the acute on chronic liver failure (aclf) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the acute on chronic liver failure (aclf) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the acute on chronic liver failure (aclf) market.
•Industry Challenges: Identify potential risks and obstacles affecting the acute on chronic liver failure (aclf) market.
•Competitive Landscape: Review strategic developments in the acute on chronic liver failure (aclf) market, including expansions, agreements, and new product launches.
The Business Research Company
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute On Chronic Liver Failure (ACLF) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3934629 • Views: …
More Releases from The Business Research Company
Comprehensive Insights Into The Global Electric Bikes And Scooters Market: Key G …
The electric bikes and scooters report outlines and analyzes the electric bikes and scooters (excluding e-mopeds or 2-wheelers) market, covering the historic period 2019-2024 and the forecast period 2024-2029 and 2034F. The study examines the market across all regions and major regional economies.
The global electric bikes and scooters (excluding e-mopeds or 2 wheelers) market was valued at approximately $43.09310 billion in 2024, reflecting a CAGR of 12.12% since 2019. The…
Geothermal Heat Pump Market Report 2025: Size, Trends, and Key Growth Insights f …
The geothermal heat pump report outlines and analyzes the geothermal heat pump market, covering 2019-2024 as the historic period and 2024-2029, 2034F as the forecast period. The report examines the market across every region and assesses major economies within each region.
The global geothermal heat pump market reached $4.40620 billion in 2024, increasing at a CAGR of 5.70% since 2019. The market is projected to grow from $4.40620 billion in 2024…
Major Growth Driver Identified in 2025 VFX In Advertising Market: The Rise Of So …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
VFX In Advertising Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past several years, the market size of vfx in advertising has seen robust growth. It is expected to expand from $2.8 billion in 2024 to a staggering $3.03 billion in 2025, exhibiting…
Driving Web Content, Search Portals And Social Media Market Growth in 2025: The …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Web Content, Search Portals And Social Media Market Size Growth Forecast: What to Expect by 2025?
The market size for web content, search portals, and social media has seen quick expansion in the past few years. It's projected to expand from $682.14 billion in 2024 to $768.29 billion in…
More Releases for ACLF
United States Acute On Chronic Liver Failure (ACLF) Market 2025 | Growth Drivers …
Market Size and Growth
Global Acute on Chronic Liver Failure market is growing at a CAGR of 6% during the forecast period 2024-2031.
Recent Mergers and acquisitions:
✅ In October 2025, Roche completed the acquisition of 89bio for up to USD 3.5 billion to strengthen its portfolio in liver and metabolic diseases. While primarily focused on MASH, the acquisition enhances Roche's long-term capabilities in liver-regeneration therapeutics, potentially extending to ACLF treatment development.
✅…
Acute On Chronic Liver Failure (ACLF) Market Report 2025-2034: Industry Overview …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Acute On Chronic Liver Failure (ACLF) Market Size and Its Estimated Growth Rate?
The market size for acute on chronic liver failure (ACLF) has been experiencing a robust expansion over the past few years. The market, valued at $2.68 billion in 2024, is projected to escalate to…
Acute On Chronic Liver Failure (ACLF) Market 2025: Growth, Applications, Innovat …
The Global Acute On Chronic Liver Failure (ACLF) Market is estimated to be valued at USD 4.43 Bn in 2025 and is expected to reach USD 6.44 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032.
A new report from CoherentMI, titled "Acute On Chronic Liver Failure (ACLF) Market 2025-2032," offers an in-depth examination of the industry, including valuable insights into the Acute…
Acute On Chronic Liver Failure (ACLF) Market: Share & Size, Forecasts a CAGR of …
According to a new report published by CoherentMI The Global Acute On Chronic Liver Failure (ACLF) Market is estimated to be valued at USD 4.2 Bn in 2024 and is expected to reach USD 6.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.
Most recent Report, named "Acute On Chronic Liver Failure (ACLF) Market" Patterns, Offer, Size, Development, Opportunity and Forecast…
Acute On Chronic Liver Failure (ACLF) Market Sector Insights, Market Share, and …
The Global Acute On Chronic Liver Failure (ACLF) Market is estimated to be valued at USD 4.2 Bn in 2024 and is expected to reach USD 6.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.
Latest Report, titled "Acute On Chronic Liver Failure (ACLF) Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by CoherentMI offers a comprehensive analysis of the industry,…
Acute On Chronic Liver Failure (ACLF) Market 2024 Size, Global Report till 2031 …
"Acute On Chronic Liver Failure (ACLF) Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Acute On Chronic Liver Failure (ACLF) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Acute On…
